These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 15371985

  • 1. Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone.
    Niemi M, Backman JT, Neuvonen PJ.
    Clin Pharmacol Ther; 2004 Sep; 76(3):239-49. PubMed ID: 15371985
    [Abstract] [Full Text] [Related]

  • 2. Effect of rifampin on the pharmacokinetics of rosiglitazone in healthy subjects.
    Park JY, Kim KA, Kang MH, Kim SL, Shin JG.
    Clin Pharmacol Ther; 2004 Mar; 75(3):157-62. PubMed ID: 15001966
    [Abstract] [Full Text] [Related]

  • 3. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T, Backman JT, Neuvonen M, Neuvonen PJ.
    Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects.
    Niemi M, Kajosaari LI, Neuvonen M, Backman JT, Neuvonen PJ.
    Br J Clin Pharmacol; 2004 Apr; 57(4):441-7. PubMed ID: 15025742
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of quercetin on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in healthy subjects.
    Kim KA, Park PW, Kim HK, Ha JM, Park JY.
    J Clin Pharmacol; 2005 Aug; 45(8):941-6. PubMed ID: 16027405
    [Abstract] [Full Text] [Related]

  • 10. Effect of ketoconazole on the pharmacokinetics of rosiglitazone in healthy subjects.
    Park JY, Kim KA, Shin JG, Lee KY.
    Br J Clin Pharmacol; 2004 Oct; 58(4):397-402. PubMed ID: 15373932
    [Abstract] [Full Text] [Related]

  • 11. Effect of multiple doses of montelukast on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in humans.
    Kim KA, Park PW, Kim KR, Park JY.
    Br J Clin Pharmacol; 2007 Mar; 63(3):339-45. PubMed ID: 16981900
    [Abstract] [Full Text] [Related]

  • 12. Effect of rifampicin on the pharmacokinetics of pioglitazone.
    Jaakkola T, Backman JT, Neuvonen M, Laitila J, Neuvonen PJ.
    Br J Clin Pharmacol; 2006 Jan; 61(1):70-8. PubMed ID: 16390353
    [Abstract] [Full Text] [Related]

  • 13. The effect of trimethoprim on CYP2C8 mediated rosiglitazone metabolism in human liver microsomes and healthy subjects.
    Hruska MW, Amico JA, Langaee TY, Ferrell RE, Fitzgerald SM, Frye RF.
    Br J Clin Pharmacol; 2005 Jan; 59(1):70-9. PubMed ID: 15606443
    [Abstract] [Full Text] [Related]

  • 14. Rifampin reduces plasma concentrations and effects of zolpidem.
    Villikka K, Kivistö KT, Luurila H, Neuvonen PJ.
    Clin Pharmacol Ther; 1997 Dec; 62(6):629-34. PubMed ID: 9433391
    [Abstract] [Full Text] [Related]

  • 15. Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations.
    Kyrklund C, Backman JT, Kivistö KT, Neuvonen M, Laitila J, Neuvonen PJ.
    Clin Pharmacol Ther; 2000 Dec; 68(6):592-7. PubMed ID: 11180018
    [Abstract] [Full Text] [Related]

  • 16. The effects of febuxostat on the pharmacokinetic parameters of rosiglitazone, a CYP2C8 substrate.
    Naik H, Wu JT, Palmer R, McLean L.
    Br J Clin Pharmacol; 2012 Aug; 74(2):327-35. PubMed ID: 22242967
    [Abstract] [Full Text] [Related]

  • 17. Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukast.
    Karonen T, Filppula A, Laitila J, Niemi M, Neuvonen PJ, Backman JT.
    Clin Pharmacol Ther; 2010 Aug; 88(2):223-30. PubMed ID: 20592724
    [Abstract] [Full Text] [Related]

  • 18. The effects of human CYP2C8 genotype and fluvoxamine on the pharmacokinetics of rosiglitazone in healthy subjects.
    Pedersen RS, Damkier P, Brosen K.
    Br J Clin Pharmacol; 2006 Dec; 62(6):682-9. PubMed ID: 16856883
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride.
    Niemi M, Backman JT, Neuvonen M, Laitila J, Neuvonen PJ, Kivistö KT.
    Clin Pharmacol Ther; 2001 Apr; 69(4):194-200. PubMed ID: 11309547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.